Crosslink Therapeutics

Boston, MA · Founded 2022 · Privately Held (backing)

Operator of a biologics platform intended to enable targeted cancer treatment using tumor-specific biochemical markers. Crosslink Therapeutics is based in Boston, MA and was founded in 2022. It has raised $8 million across 1 recorded round; the latest was a $4.3 million seed round in Apr 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$8.0M
Last round
Seed Round
Apr 2025
How much has Crosslink Therapeutics raised?
$8.0Macross 1 recorded rounds · Apr 2025 – Apr 2025

Most recently, Crosslink Therapeutics raised $4.3M in its Seed Round (Apr 2025).

Free account
More of Crosslink Therapeutics with a free account
  • ·Watch Crosslink Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Crosslink Therapeutics round by round

1 rounds
Apr 2025Seed Round$4.3MSEC filing▮
6 investors participated

How much has Crosslink Therapeutics raised?

Crosslink Therapeutics has raised $8 million in total; 1 of its rounds is on record. The largest on record was a $4.3 million seed round in Apr 2025.

Crosslink Therapeutics has filed 1 Form D with the SEC, most recently in May 2025 ($4.3 million sold to 6 investors).

Crosslink Therapeutics investors

5 investors are on record for Crosslink Therapeutics, including Highlight Capital, TIFF Investment Management, Cure Ventures and Rivas Capital. The seed round in Apr 2025 drew 6 investors.

For fundraisers
Raising for a company like Crosslink Therapeutics?

5 investors have backed Crosslink Therapeutics.

See all 5 investors →

Frequently asked about Crosslink Therapeutics

How much has Crosslink Therapeutics raised?
Crosslink Therapeutics has raised $8.0M in total across 1 recorded funding rounds.
When was Crosslink Therapeutics's last funding round?
Crosslink Therapeutics's most recent recorded round was Seed Round in Apr 2025, raising $4.3M.